Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) OCF Margin %: -0.33% (As of Mar. 2026)


NSE:MADHAVBAUG Vaidya Sane Ayurved Laboratories Ltd NSE:MADHAVBAUG
80 GF Score
Price ₹187.00
GF Value ₹228.09
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Vaidyane Ayurved Laboratories OCF Margin %?

Vaidyane Ayurved Laboratories NSE:MADHAVBAUG +2.05% 80 OCF Margin % is -0.33% as of Mar. 2026. GuruFocus rates NSE:MADHAVBAUG with a GF Score™ of 80/100 and a GF Value™ of ₹228.09 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 961 Drug Manufacturers companies, Vaidyane Ayurved Laboratories ranks worse than 60.87% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Vaidyane Ayurved Laboratories's Cash Flow from Operations for the six months ended in Mar. 2026 was ₹-2 Mil. Vaidyane Ayurved Laboratories's Revenue for the six months ended in Mar. 2026 was ₹570 Mil. Therefore, Vaidyane Ayurved Laboratories's OCF Margin % for the quarter that ended in Mar. 2026 was -0.33%.

As of today, Vaidyane Ayurved Laboratories's current OCF Yield % is 2.85%.

The historical rank and industry rank for Vaidyane Ayurved Laboratories's OCF Margin % or its related term are showing as below:

NSE:MADHAVBAUG' s OCF Margin % Range Over the Past 10 Years
Min: -17.57   Med: 3.8   Max: 28.58
Current: 5.06


During the past 8 years, the highest OCF Margin % of Vaidyane Ayurved Laboratories was 28.58%. The lowest was -17.57%. And the median was 3.80%.

NSE:MADHAVBAUG's OCF Margin % is ranked worse than
60.87% of 961 companies
in the Drug Manufacturers industry
Industry Median: 9.94 vs NSE:MADHAVBAUG: 5.06


Vaidyane Ayurved Laboratories OCF Margin % Related Terms


Vaidyane Ayurved Laboratories OCF Margin % Historical Data

* Premium members only.

The historical data trend for Vaidyane Ayurved Laboratories's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaidyane Ayurved Laboratories OCF Margin % Chart

Vaidyane Ayurved Laboratories Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
Get a 7-Day Free Trial -17.57 0.06 -1.27 28.58 5.06

Vaidyane Ayurved Laboratories Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.24 16.02 8.11 11.21 -0.33

NSE:MADHAVBAUG vs ZTS, UTHR: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaidyane Ayurved Laboratories OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Vaidyane Ayurved Laboratories's OCF Margin % falls into.


NSE:MADHAVBAUG
80GF Score
Vaidya Sane Ayurved Laboratories Ltd NSE:MADHAVBAUG
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaidyane Ayurved Laboratories OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Vaidyane Ayurved Laboratories's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=54.114/1069.064
=5.06 %

Vaidyane Ayurved Laboratories's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-1.858/569.623
=-0.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -0.33% mean?
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) has a OCF Margin % of -0.33% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vaidyane Ayurved Laboratories and its competitors. According to the industry distribution chart, Vaidyane Ayurved Laboratories ranks #585 out of 961 companies in the Drug Manufacturers industry, placing it in the top 60.9%.
Is Vaidyane Ayurved Laboratories' OCF Margin % too high?
Vaidyane Ayurved Laboratories' current OCF Margin % is -0.33%. Based on the distribution chart, Vaidyane Ayurved Laboratories ranks #585 out of 961 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Vaidyane Ayurved Laboratories has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vaidyane Ayurved Laboratories' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vaidyane Ayurved Laboratories ranks #585 out of 961 companies for OCF Margin %. This places Vaidyane Ayurved Laboratories in the lower half of its industry. The industry median OCF Margin % is 9.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vaidyane Ayurved Laboratories and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaidyane Ayurved Laboratories's current OCF Margin % is -0.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaidyane Ayurved Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹228.09, compared to a current price of ₹187.00 — trading 18% below its estimated fair value. The current OCF Margin % is -0.33%. Vaidyane Ayurved Laboratories' overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG), the current OCF Margin % is -0.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Overvalued in 2026?

Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories stock appears to be undervalued. The current stock price of ₹187.00 is trading 18% below its estimated GF Value™ of ₹228.09. GuruFocus considers Vaidyane Ayurved Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:MADHAVBAUG:

  • OCF Margin %: -0.33%
  • GF Value™: ₹228.09 vs. price of ₹187.00 (18% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the NSE:MADHAVBAUG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vaidyane Ayurved Laboratories Business Description

Address 201B, Bhoomi Velocity, Above ICICI Bank, Road No. 23, Wagle Estate, Thane (West), Thane, MH, IND, 400604
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution. The company engaged in research and development in Ayurvedic Medicines and the sale of Ayurvedic medicines & products through its various franchises and own clinics. The Company is also engaged in providing Ayurved medical professional services across its various clinics, including panchkarma and other Ayurvedic treatments through the running of an Ayurvedic Hospital. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management, and knee pain relief. The company's business is divided into three segments, i.e., Hospital Activity, Sale of Product, and Common. It derives maximum revenue from the sale of Products.
80GF Score

Get the complete analysis for NSE:MADHAVBAUG

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹187.00
Price
₹228.09
GF Value